Product Description
| Cat Number | KS-060 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | cAMP-dependent protein kinase (PKA) inhibitor |
| Modification | C terminal amide |
| Purity | >95% by HPLC |
| Biomarker Target | Kinases |
| Sequence Three Letter Code | H-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 |
| Molecular Formula | C80H130N28O24 |
| Sl Sequence | TYADFIASGRTGRRNAI-NH2 |
| Solubility | Soluble in dilute acid |
| Appearance | Freeze dried solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Glass et al (1989) Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J.Biol.Chem. 264 8802 PMID: 2722799Glass et al (1989) Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. J.Biol.Chem. 264 14579 PMID: 2760075Otmakhova et al (2000) Inhibition of the cAMP pathway decreases early long-term potentiation at CA1 hippocampal synapses. J.Neurosci. 20 4446 PMID: 10844013 Related dataAll peptides >All kinase modulators >All neuroscience research categories > |
| Note | The product is for research use only |
Share Item: